Health Care: Drugs

OncoMed Pharmaceuticals Inc (OMED: NASDAQ)

$3.6801 0.1601 | 4.55%
05/26/17 - 10:33 AM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 25.15M 25.90M 39.56M 37.78M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 25.15M 25.90M 39.56M 37.78M
Selling, General, and Administrative Expenses 18.83M 18.58M 13.75M 11.63M
Research & Development 109.71M 92.87M 76.43M 50.05M
Operating Income before D & A (EBITDA) -103.39M -85.56M -50.62M -23.90M
Depreciation & Amortization 1.76M 1.64M 1.43M 1.38M
Interest Income 299.00K 170.00K 105.00K 0.00
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -104.85M -87.03M -51.95M -25.28M
Interest Expense 0.00 0.00 0.00 228.00K
Pre-Tax Income -104.85M -87.03M -51.95M -25.50M
Income Taxes 14.00K 20.00K -509.00K 1.94M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -103.10M -85.41M -50.01M -26.07M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -103.10M -85.41M -50.01M -26.07M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -103.10M -85.41M -50.01M -26.07M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-103.10M -85.41M -50.01M -26.07M
Preferred Dividends
Net Income Available To Common -103.10M -85.41M -50.01M -26.07M
Basic EPS from Continuing Ops. -3.14 -2.84 -1.69 -1.93
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -3.14 -2.84 -1.69 -1.93
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -3.14 -2.84 -1.69 -1.93
Basic Normalized Net Income/Share -3.14 -2.84 -1.69 -1.93
EPS fr Continuing Ops. -3.14 -2.84 -1.69 -1.93
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -3.14 -2.84 -1.69 -1.93
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -3.14 -2.84 -1.69 -1.93
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-3.14 -2.84 -1.69 -1.93
Dividends Paid per Share 0.00 0.00 0.00 0.00

Partner Headlines for OMED

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter